Troponin News and Research

RSS

Two Roche Diagnostic tests identified as transformative products for rapid uptake

Roche Diagnostics tests for suspected pre-eclampsia and heart attack have been recognized as ‘transformative’ and have been selected among only seven Rapid Uptake Products for the NHS.

From Roche Sequencing and Life Science 23 Oct 2018

Midazolam-mediated alterations of PER2 expression may have functional consequences during myocardial ischemia

Innovative cardioprotective strategies are of imminent demand. Nonfatal myocardial ischemia (MI) poses a significant risk to patients undergoing major non-cardiac surgery and these non-cardiac surgeries account for around 8 million myocardial injuries per year

19 Oct 2018

HEART Pathway protocol identifies ED patients with acute chest pain

A relatively new accelerated diagnostic protocol is effective in identifying emergency department patients with acute chest pain who can be safely sent home without being hospitalized or undergoing comprehensive cardiac testing, according to researchers at Wake Forest Baptist Medical Center.

28 Sep 2018

Imaging with CMR can improve detection of cardiac injury in lupus patients

The number of diagnoses of systemic lupus erythematodes has tripled over the past 45 years - due in part to improved diagnostic methods.

7 Sep 2018

New trial assesses criteria used to diagnose myocardial infarction

Results of the first randomized trial testing the criteria used to diagnose heart attack are presented today in a Hot Line Session at ESC Congress 2018 and published in The Lancet.

28 Aug 2018

$Study: Microvascular dysfunction can be major cause of heart failure with preserved ejection fraction$

Study: Microvascular dysfunction can be major cause of heart failure with preserved ejection fraction

Microvascular dysfunction, or small vessel disease, can be an important cause of heart failure with preserved ejection fraction (preserved pumping capacity), an international team including researchers from Karolinska Institutet and AstraZeneca report in a study published in The European Heart Journal.

27 Aug 2018

Study finds main reasons why people die after noncardiac surgery

The main reasons why people die after noncardiac surgery are revealed today in a study of more than 40,000 patients from six continents presented in a late breaking science session at ESC Congress 2018.

27 Aug 2018

New guidance helps clear up confusion over how to diagnose heart attack

Confusion over how to diagnose a heart attack is set to be cleared up with new guidance launched today. The 2018 Fourth Universal Definition of Myocardial Infarction is published online in European Heart Journal, and on the ESC website.

25 Aug 2018

New high-sensitivity blood test quickly rules out heart attack in emergency room patients

A new test to assess a whether or not someone is having a heart attack upon arriving in the emergency room was safe and effective, ruling out heart attack in emergency room patients faster than a conventional method, according to new research in the American Heart Association's journal Circulation.

6 Aug 2018

High-sensitive troponin T detects more cardiac infarctions than conventional ones, shows study

Five percent more cardiac infarctions detected and 11 percent fewer patients suffering a relapse. That is the result of a study of more than 80,000 patients in which two cardiac damage markers were compared with each other.

8 Jun 2018

Patients diagnosed with high-sensitivity troponin test have lower risk of future heart attack

The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than before.

5 Jun 2018

HCM mutation prevents the heart from increasing pumping force, study shows

Researchers from Washington State University have discovered how a genetic mutation linked to hypertrophic cardiomyopathy (HCM) disrupts the heart's normal function.

21 May 2018

Researchers design creative new approach to regenerate injured hearts

Heart disease is a major global health problem--myocardial infarction annually affects more than one million people in the U.S. alone, and there is still no effective treatment.

24 Apr 2018

New blood test promises to eliminate guesswork in heart attack diagnosis

A new blood test developed by a University of Alberta physician promises to eliminate the guesswork clinicians face with an apparent heart attack.

15 Mar 2018

The Importance of Fetal Fibronectin Testing for Women with Symptomatic Preterm Labor

Preterm birth is a dangerous condition that often goes undiagnosed. Fetal fibronectin (fFN) is a biomarker for preterm labor, but testing for fFN is widely underused. We explore this issue with Dr. Michael S. Ruma, a maternal-fetal specialist from the Perinatal Associates of New Mexico.

14 Mar 2018

New version of troponin test can detect heart attack within one hour

When Marc Hammer went to the emergency room feeling fatigued and dizzy, he had no idea his life was actually at risk. "I'm an avid cyclist and walk five to 15 miles a day," said Hammer, "so you can imagine my shock when I found out I was facing a heart issue. It came out of the blue."

8 Mar 2018

Machine learning can help accurately predict clinical outcomes in patients with heart problems

Several studies being presented at the American College of Cardiology's 67th Annual Scientific Session demonstrate how the computer science technique known as machine learning can be used to accurately predict clinical outcomes in patients with known or potential heart problems.

1 Mar 2018

New high-sensitivity blood tests could aid faster diagnosis and treatment for heart attack

When diagnosing a heart attack, accuracy and timing are everything. A new test designed to better measure levels of troponin, a protein released when the heart muscle is damaged, could help emergency department physicians provide faster diagnosis and appropriate treatment.

16 Jan 2018

Aggressive testing unnecessary for patients who go to ER with chest pain, study suggests

Patients who go to the emergency room (ER) with chest pain often receive unnecessary tests to evaluate whether they are having a heart attack, a practice that provides no clinical benefit and adds hundreds of dollars in health-care costs, according to a new study from researchers at Washington University School of Medicine in St. Louis.

15 Nov 2017

Rapid blood test that spots heart attack risk could improve treatment of people with chest pain

A low-cost, rapid blood test that spots whether people are at risk of a heart attack could improve the treatment of people with chest pain at emergency departments around the world, a study suggests.

13 Nov 2017